BOP1通过DUSP6/MAPK路径促进前列腺癌
Xiaoqing Wu1, Zheng Jing1, Tianpu Huang1
1Department of Radiotherapy, Central Hospital Affiliated to Shandong First Medical University, 250000 Jinan, Shandong, China.
Archivos espanoles de urologia
|September 8, 2023
概括
增殖阻断1 (BOP1) 促进前列腺癌 (CaP) 的进展. 博普1对双特异性酸酶6 (DUSP6) 进行上调,激活MAPK通路,推动CaP的发展和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 核突突出是前列腺癌 (CaP) 的关键生物标志物.
- 核蛋白增殖阻断1 (BOP1) 涉及到CaP的发展,并呈现出潜在的治疗标.
研究的目的:
- 阐明BOP1在前列腺癌进展中的潜在机制.
- 研究BOP1在调节细胞活力,细胞亡和CaP转移中的作用.
主要方法:
- 在CaP组织和PC3细胞中评估BOP1表达.
- 评估了BOP1对PC3细胞活力,细胞亡和转移在体外的影响.
- 分析了BOP1对基激活蛋白激酶 (MAPK) 途径的影响及其对双特异性酸酶6 (DUSP6) 的调节.
主要成果:
- 在CaP组织和细胞中,BOP1和DUSP6被上调.
- 抑制BOP1降低了PC3细胞活力,诱导了亡,并抑制了转移.
- BOP1淘汰赛抑制了DUSP6表达和MAPK通路;DUSP6过度表达挽救了这些效应.
结论:
- 通过调节DUSP6并激活MAPK通路,BOP1促进了CaP的进展.
- 针对BOP1/DUSP6/MAPK轴为前列腺癌提供了一个潜在的治疗策略.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


